WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CTNM earnings and revenue history

Current Revenue
$50.0M
Current Earnings
$3.1M
Current Profit Margin
6.3%

CTNM Return on Equity

Current Company
-3.9%
Current Industry
-63.5%
Current Market
60.5%

Be the first to know when CTNM announces earnings.

CTNM Return on Assets

Current Company
3.5%
Current Industry
2.9%

CTNM Return on Capital Employed

Current Company
3.05%
Current Industry
19.5%

CTNM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABVC$152.43k-$7.74M-$10.52M-31.73%N/A
ABCL$38.03M-$143.14M-$146.40M+33.91%N/A
AMLX$380.79M$55.39M$49.27M+304.24%N/A
ACAD$726.44M-$45.48M-$61.29M+26.55%N/A
ADIL$0.00-$5.12M-$5.12MN/AN/A
View Top Biotech Stocks

Contineum Therapeutics Earnings & Revenue FAQ

What were CTNM's earnings last quarter?

Contineum Therapeutics (NASDAQ: CTNM) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Contineum Therapeutics earnings for the quarter were N/A. In the same quarter last year, Contineum Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.

What was CTNM's earnings growth in the past year?

As of Q2 2024, Contineum Therapeutics's earnings has grown year over year. Contineum Therapeutics's earnings in the past year totalled $3.15 million.

What was CTNM's revenue last quarter?

Contineum Therapeutics (NASDAQ: CTNM) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Contineum Therapeutics's revenue was N/A.

What was CTNM's revenue growth in the past year?

As of Q2 2024, Contineum Therapeutics's revenue has grown null year over year. Contineum Therapeutics's revenue in the past year totalled $50.00 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.